Glotin Duo Tablets 2.5/850 Mg (linagliptin | Metformin Hydrochloride)

Recall Summary Glotin Duo Tablets 2.5/850 mg, a diabetes medication distributed by Nexpharm Korea Co., Ltd. in South Korea, are being recalled because testing found an impurity called N-nitroso-meglumine at levels higher than allowed. This recall affects products with barcodes 8806625046001 and 8806625046018.

Recalling firm
Nexpharm Korea Co., Ltd.
Product
글로틴듀오정2.5/850mg(리나글립틴|메트포르민염산염) (Barcode: 8806625046001, 8806625046018)
Reason
Detection of an impurity (N-nitroso-meglumine) exceeding the permissible limit
Classification
Class II
Category
drug recall
Country
South Korea
Agency
MFDS-DRUG
Recall date
2026-06-24
Status
Ongoing
Distribution
South Korea

Official recall notice from MFDS-DRUG

Recall details on Nibble Recalls: https://trynibble.app/recalls/b3df08e4-6512-4433-bf80-f80c5d5d6c7f